Tenaya Therapeutics, Inc. (TNYA) DCF Valuation

Tenaya Therapeutics, Inc. (TNYA) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Tenaya Therapeutics, Inc. (TNYA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain mastery over your Tenaya Therapeutics, Inc. (TNYA) valuation analysis using our sophisticated DCF Calculator! Preloaded with real (TNYA) data, this Excel template enables you to adjust forecasts and assumptions for an accurate calculation of Tenaya Therapeutics' intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -25.7 -36.4 -68.7 -115.0 -122.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 2.0 2.5 4.0 8.7 8.7 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -27.7 -38.9 -72.7 -123.7 -131.2 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 26.6 128.5 251.3 204.2 104.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 -19.9 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .6 1.0 10.7 9.6 5.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -2.9 -9.8 -25.1 -20.6 -1.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -27.2 -38.8 -69.7 -123.7 -131.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -27.6 -45.7 -81.0 -116.8 -147.6 -5.6 .0 .0 .0 .0
WACC, % 14.4 14.41 14.39 14.41 14.41 14.4 14.4 14.4 14.4 14.4
PV UFCF
SUM PV UFCF -4.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -5
Net Debt -33
Equity Value 28
Diluted Shares Outstanding, MM 74
Equity Value Per Share 0.38

What You Will Get

  • Real TNYA Financial Data: Pre-filled with Tenaya Therapeutics’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Tenaya Therapeutics’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Tenaya Therapeutics, Inc. (TNYA).
  • WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs for precise calculations.
  • Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates to suit your analysis.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Tenaya Therapeutics, Inc. (TNYA).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.

How It Works

  1. Download the Template: Obtain immediate access to the Excel-based TNYA DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
  3. Instant Calculations: The model automatically recalculates Tenaya Therapeutics' intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation fluctuations.
  5. Analyze and Decide: Utilize the findings to inform your investment or financial evaluation.

Why Choose Tenaya Therapeutics, Inc. (TNYA)?

  • Innovative Solutions: Cutting-edge therapies aimed at addressing unmet medical needs.
  • Strong Scientific Foundation: Backed by robust research and clinical data to ensure efficacy.
  • Patient-Centric Approach: Focused on improving patient outcomes and quality of life.
  • Experienced Team: Led by industry veterans with a proven track record in biotechnology.
  • Commitment to Excellence: Striving for the highest standards in drug development and safety.

Who Should Use Tenaya Therapeutics, Inc. (TNYA)?

  • Investors: Gain insights into innovative therapies and make informed investment choices.
  • Healthcare Analysts: Streamline your research with comprehensive data on regenerative medicine.
  • Consultants: Easily customize presentations for clients focusing on biotech advancements.
  • Biotech Enthusiasts: Enhance your knowledge of cutting-edge treatments and industry trends.
  • Educators and Students: Utilize it as a hands-on resource in life sciences and biotechnology courses.

What the Template Contains

  • Pre-Filled Data: Includes Tenaya Therapeutics’ historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Tenaya Therapeutics’ profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.